For the third quarter of 2024, Ascendis Pharma reported a net loss of €99.2 million, or €1.72 per share (basic and diluted) ...

The study also identifies pathogens such as Group A streptococcus and Klebsiella pneumoniae as top disease control priorities in all regions.

Our study reveals the troubling truth about disease awareness campaigns – almost 75 per cent are being influenced by companies that stand to gain financially, raising serious ethical concerns. Making ...

Scientists have shared details of how they are going about updating foodborne infection figures that will be published by the ...

Oregon confirms its first human bird flu case, the latest in dozens of cases in the U.S. this year. Experts discuss the ...

Announcing a new publication for Acta Materia Medica journal. Celastrol is an active compound from the root of Tripterygium ...

In a groundbreaking study, researchers at McMaster University have identified a potential treatment for Sandhoff and Tay-Sachs diseases—two rare, often fatal lysosomal storage disorders that cause ...

Robert F. Kennedy Jr., and his wife Cheryl Hines arrive before President-elect Donald Trump speaks during an America First ...

The CDC did not break out most data for county or region, but for New York State in 2023, there were 12,393 cases of all ...

The company is focusing on its pipeline of treatments for infectious diseases, especially hepatitis B and D, as well as new oncology assets acquired from Sanofi. While there is potential in these ...

The multidrug-resistant form of Tuberculosis remains a public health crisis. Tuberculosis replaced COVID-19 to become the top cause of infectious disease-related deaths in 2023, according to a ...